Neoplastic development in plasma cells

10.1016/S1074-7613(02)00389-8

10.1016/S1074-7613(02)00335-7

10.1016/S1074-7613(00)00020-0

10.1038/ni1201-1103

10.1002/eji.1830270935

10.1038/35085509

10.1084/jem.20011626

10.1093/intimm/10.11.1703

10.3181/00379727-101-24970

Merwin RM, 1963, Induction of plasma cell tumors and sarcomas in mice by diffusion chambers placed in the peritoneal cavity, J Natl Cancer Inst, 31, 990

10.1111/j.1600-065X.1994.tb00660.x

10.1093/intimm/1.1.75

10.1007/978-3-642-57284-5_13

10.1002/eji.1830230104

Athanassiades TJ, 1968, Formation of antigen‐induced granulomas containing plasma cells: a light and electron microscopic study, J Reticuloendothelial Soc, 5, 485

Athanassiades TJ, 1972, Granuloma induction in the peritoneal cavity. A model for the study of inflammation and plasmacytopoiesis in non‐lymphatic organs, J Reticuloendothelial Soc, 11, 60

10.1016/0014-4894(92)90203-M

Potter M, 1997, Indomethacin is a potent inhibitor of pristane and plastic disc induced plasmacytomagenesis in a hypersusceptible BALB/c congenic strain, Blood, 90, 260, 10.1182/blood.V90.1.260.260_260_269

10.1093/jnci/86.14.1058

Takakura K, 1966, Studies on the pathogenesis of plasma cell tumors. I. Effect of cortisol on development of plasma cell tumors, Cancer Res, 26, 596

10.1126/science.3726549

10.1073/pnas.93.10.4885

Potter M, 1994, Identification of two genes on chromosome 4 that determine resistance to plasmacytoma induction in mice, Cancer Res, 54, 969

10.1073/pnas.90.15.7361

10.1038/sj.onc.1201156

10.1073/pnas.95.1.189

10.1084/jem.20011521

Muller JR, 1996, Detection of immunoglobulin/c‐myc recombinations in mice that are resistant to plasmacytoma induction, Cancer Res, 56, 419

Muller JR, 1997, Migration of cells with immunoglobulin/ c‐myc recombinations in lymphoid tissues of mice, Blood, 89, 291, 10.1182/blood.V89.1.291

10.1016/S0959-437X(01)00266-0

10.1182/blood.V82.12.3712.3712

10.1038/sj.onc.1202997

Vaux DL, 1987, Immunologic competence of B cells subjected to constitutive c‐myc oncogene expression in immunoglobulin heavy chain enhancer myc transgenic mice, J Immunol, 139, 3854, 10.4049/jimmunol.139.11.3854

10.1016/S0959-437X(05)80339-9

10.1038/35077213

10.1126/science.281.5381.1317

10.1016/S0092-8674(02)00738-9

10.1016/S1097-2765(00)80367-6

10.1073/pnas.90.20.9499

10.1073/pnas.95.5.2429

10.1128/MCB.21.1.310-318.2001

10.1038/sj.onc.1206257

10.1093/jnci/94.6.446

Namba Y, 1972, Immunocytology of cultured IgM‐forming cells of mouse. I. Requirement of phagocytic cell factor for the growth of IgM‐forming tumor cells in tissue culture, J Immunol, 109, 1193

10.1016/0008-8749(74)90058-6

10.1002/jcp.1040810312

10.1182/blood.V74.1.1.1

Billiau A, 1987, Mechanisms of B Cell Neoplasia., 87

10.1007/978-3-642-71562-4_14

10.1084/jem.165.3.641

Potter M, 1972, Growth of primary plasmacytomas in the mineral oil‐conditioned peritoneal environment, J Natl Cancer Inst, 49, 305

10.1084/jem.182.1.243

10.1073/pnas.90.5.2060

10.1084/jem.172.3.997

10.1038/sj.leu.2400564

Le J, 1988, Tumor necrosis factor and interleukin 1 can act as essential growth factors in a murine plasmacytoma line, Lymphokine Res, 7, 99

10.1182/blood-2002-01-0102

10.1182/blood.V97.6.1817

Lattanzio G, 1997, Defective development of pristane‐oil‐induced plasmacytomas in interleukin‐6‐deficient BALB/c mice, Am J Pathol, 151, 689

10.1038/22788

10.1038/71691

10.1073/pnas.85.16.6067

10.1073/pnas.86.24.9941

10.1126/science.3810165

10.1002/j.1460-2075.1990.tb08187.x

10.1126/science.182.4112.592

10.1002/ijc.2910440227

10.1084/jem.159.6.1762

Largaespada DA, 1992, A retrovirus that expresses v‐abl and c‐myc oncogenes rapidly induces plasmacytomas, Oncogene, 7, 811

10.1002/(SICI)1097-0215(19960703)67:1<142::AID-IJC23>3.0.CO;2-F

10.2741/A767

10.1073/pnas.86.19.7547

10.1073/pnas.89.1.232

10.1016/S0002-9440(10)65605-2

10.1089/dna.1992.11.587

10.1073/pnas.022643999

Strasser A, 1993, E mu‐bcl‐2 transgene facilitates spontaneous transformation of early pre‐B and immunoglobulin‐secreting cells but not T cells, Oncogene, 8, 1

Silva S, 1999, Plasmacytoma induction in specific pathogen‐free (SPF) bcl‐2 transgenic BALB/c mice, Curr Top Microbiol Immunol, 246, 379

10.1016/S0959-437X(01)00265-9

10.1084/jem.183.1.227

10.1038/sj.cdd.4400758

10.1038/sj.onc.1204892

10.1038/335440a0

10.1016/0092-8674(89)90174-8

10.1016/S1074-7613(00)80437-9

10.1016/S1074-7613(00)80586-5

10.1084/jem.183.2.381

Radl J, 1974, Homogeneous immunoglobulins in sera of mice during aging, J Immunol, 112, 2271, 10.4049/jimmunol.112.6.2271

Radl J, 1980, Idiopathic paraproteinemia. III. Increased frequency of paraproteinemia in thymectomized aging C57BL/KaLwRij and CBA/BrARij mice, J Immunol, 125, 31, 10.4049/jimmunol.125.1.31

10.1159/000234667

10.1111/j.1365-3083.1988.tb01461.x

Radl J, 1979, Idiopathic paraproteinemia. II. Transplantation of the paraprotein‐producing clone from old to young C57BL/KaLwRij mice, J Immunol, 122, 609

Radl J, 1981, Animal model of human disease. Benign monoclonal gammopathy (idiopathic paraproteinemia), Am J Pathol, 105, 91

10.1038/bjc.1992.415

10.1038/bjc.1987.241

10.1038/bjc.1990.51

Asosingh K, 2001, A unique pathway in the homing of murine multiple myeloma cells: CD44v10 mediates binding to bone marrow endothelium, Cancer Res, 61, 2862

10.1046/j.1468-0734.2002.00076.x

10.1128/jvi.69.3.1895-1902.1995

10.1902/jop.1983.54.4.227

10.1046/j.1365-3083.1998.00471.x

10.1002/(SICI)1097-0142(19971015)80:8 <1538::AID-CNCR3>3.0.CO;2-G

10.1677/joe.0.1730387

10.1111/j.1365-2141.1982.tb03936.x

10.1046/j.1365-2141.1998.01082.x

10.1002/cncr.11133

10.1016/S1359-6101(02)00045-X

10.1182/blood.V96.2.671

10.1182/blood.V98.13.3527

10.1046/j.1365-2141.2002.03417.x

10.1002/cncr.11134

10.1182/blood.V98.13.3534

10.1182/blood-2002-09-2684

10.1200/JCO.2002.20.1.353

10.1182/blood-2002-01-0148

Klein B, 1995, Cytokine, cytokine receptors, transduction signals, and oncogenes in human multiple myeloma, Semin Hematol, 32, 4

Barille S, 1995, Myeloma cells upregulate interleukin‐6 secretion in osteoblastic cells through cell‐to‐cell contact but downregulate osteocalcin, Blood, 86, 3151, 10.1182/blood.V86.8.3151.3151

Barille S, 2000, The role of interleukin‐6 and interleukin‐6/interleukin‐6 receptor‐alpha complex in the pathogenesis of multiple myeloma, Eur Cytokine Netw, 11, 546

10.1182/blood.V83.12.3654.3654

10.1172/JCI114392

10.1016/S0889-8588(18)30343-5

10.1182/blood.V90.2.754

10.1006/smim.1996.0024

10.1182/blood.V92.8.2908

10.1182/blood.V94.10.3576.422k01_3576_3582

Foulds L, 1969, Neoplastic Development

10.1038/1931086a0

10.1038/222994a0

Anderson PN, 1970, Plasma cell tumor induction in BALB/c mice, Proc Am Assoc Cancer Res, 11, 3

Potter M, 1983, Peritoneal plasmacytomagenesis in mice: comparison of different pristane dose regimens, J Natl Cancer Inst, 71, 391

Potter M, 1960, Development of plasma‐cell neoplasms in BALB/c mice after intraperitoneal injection of paraffin‐oil adjuvant, heat‐killed staphylococcus mixtures, J Natl Cancer Inst, 25, 847, 10.1093/jnci/25.4.847

10.1007/BF01572270

10.4049/jimmunol.127.4.1591

Potter M, 1984, Genetics of susceptibility to plasmacytoma development in BALB/c mice, Cancer Surv, 3, 247

10.1084/jem.161.5.996

Byrd LG, 1991, Specific pathogen‐free BALB/cAn mice are refractory to plasmacytoma induction by pristane, J Immunol, 147, 3632, 10.4049/jimmunol.147.10.3632

Mandel MA, 1972, The effects of heterologous anti‐thymocyte sera in mice. V. Enhancement of plasma cell tumor induction, J Immunol, 109, 360

10.1172/JCI114749

10.1038/sj.leu.2401676

10.1016/S0065-230X(08)60200-6

10.1002/j.1460-2075.1985.tb03682.x

10.1016/S0065-230X(08)60440-6